-
-
In this paper, daccarett and colleagues from the University of Utah assessed the potential contribution of cardiac magnetic resonance imaging for detection of left atrial fibrosis to risk stratify patients for stroke with atrial fibrillation.
-
Atrial septal defects (asd) are the most frequent congenital heart defects. Closure of the defect (either surgically or percutaneously) is a Class 1 recommendation in the ACC/AHA guidelines for management of adults with congenital heart disease when there is right heart dilation.
-
Patients presenting with acute coronary syndromes (ACS) should be administered dual anti-platelet therapy with aspirin and a thienopyridine, such as clopidogrel. However, some patients are subsequently found to have left main (LM) or multivessel disease (MVD) and require coronary artery bypass graft (CABG) surgery. For patients who have been loaded with clopidogrel, early CABG can result in excess bleeding:
-
Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
The madit-crt trial compared the effects of implanting defibrillators with and without resynchronization therapy in patients with New York Heart Association (NYHA) functional class I and II heart failure symptoms,
-
The heartmate ii left ventricular assist device (LVAD) is a continuous flow device compared to the pulsatile flow Heartmate I.
-
The source of embolic thrombotic material in patients with cryptogenic stroke is controversial.
-
In animal models, aspirin (asa) has favorable effects on the incidence and/or growth rate of some cancers (CA).
-
A broad-spectrum, parenteral, cephalosporin with activity against both gram-positive and gram-negative bacteria has been approved by the FDA. Ceftaroline fosamil is the prodrug of ceftaroline and is marketed by Forest Pharmaceuticals as Teflaro™.